The antiviral compounds, including GC376, showed antiviral effects against SARS-CoV-2 in human ACE-2–expressing transgenic mice (27, 40, 43) or in rhesus macaques (25) with nonlethal infection. This evidence concerns the gene ACE2 and infection.